A South Wales pensioner has used his chronic illness to create a digital platform that could save the NHS millions of pounds and make a huge difference to patients’ lives.
Ian Bond, 73, was diagnosed with
He is one of 3 million people in the UK with the condition, which costs the NHS £2bn each year.
Ian began keeping a comprehensive diary of ‘wellness points’ to track sleep quality, exercise, breathlessness, coughing, peak flow readings and any medication changes.
This diary meant Mr Bond’s doctor appointments became evidence-based and formed the foundation for treatment.
Ian Bond and partner Dave Taylor set up Bond Digital Health Ltd. at the Life Sciences Hub Wales in
Bond Digital Health has now developed a range of digital products targeted at individual patients, medical practitioners and clinical developers.
The business has already achieved half a million pounds of commercial contracts in its first six months of trading, including orders for its digital toolkit for clinical devices developed for its
The contracts have allowed the company to take on new members of staff and it is now preparing for an investment round of £1m to accelerate the business further.
Ian said: “The system we have developed allows patients to take responsibility for their own health and take control of their condition, allowing them to have a more constructive dialogue with their doctor, nurse or specialist.”
The system has the potential to be of huge benefit to the NHS, giving medical practitioners access to more detailed patient data and consequently delivering more cost-effective and personalised treatments.
When fully implemented it will spot patient "crisis points” before they occur, allowing early intervention and saving the NHS money in emergency hospitalisations, which is very common with lung disease.
Bond Digital Health technical director Dave Taylor said: “The support of the Life Sciences Hub Wales was invaluable. Networking with other Hub members allowed us to make vital collaborations that boosted our visibility and helped turn our idea into a viable business.”
Keir Lewis, professor of respiratory medicine at Swansea University and one of the foremost pulmonary experts in Wales, advised the team on the product’s suitability for the NHS and has since joined the board as a non-executive director.
He said: “This is a remarkable achievement. Ian and Dave have developed a platform that is comprehensive and yet simple to use.
“Not only does it have a range of uses in treating COPD, but it is flexible enough to evolve to help treat other conditions and diseases.
“Most importantly, this is something patients and doctors can use in the real world.”
Image caption (left to right): Professor Keir Lewis; Dave Taylor, co-founder and Technical Director, Ian Bond CEO & founder, Phil Groom Commercial Director; Vicky Agova Market Analyst and Researcher, Rui Zhang Senior Developer.